216 related articles for article (PubMed ID: 9234736)
1. Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.
Topol LZ; Marx M; Laugier D; Bogdanova NN; Boubnov NV; Clausen PA; Calothy G; Blair DG
Mol Cell Biol; 1997 Aug; 17(8):4801-10. PubMed ID: 9234736
[TBL] [Abstract][Full Text] [Related]
2. Cloning of the murine Drm gene (Cktsf1b1) and characterization of its oncogene suppressible promoter.
Zhang Q; Topol LZ; Athanasiou M; Copeland NG; Gilbert DJ; Jenkins NA; Blair DG
Cytogenet Cell Genet; 2000; 89(3-4):242-51. PubMed ID: 10965135
[TBL] [Abstract][Full Text] [Related]
3. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a novel gene down-regulated by v-src.
Pan J; Nakanishi K; Yutsudo M; Inoue H; Li Q; Oka K; Yoshioka N; Hakura A
FEBS Lett; 1996 Mar; 383(1-2):21-5. PubMed ID: 8612783
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts.
Ozaki T; Sakiyama S
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2593-7. PubMed ID: 8385338
[TBL] [Abstract][Full Text] [Related]
6. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
You M; Ku PT; Hrdlicková R; Bose HR
Mol Cell Biol; 1997 Dec; 17(12):7328-41. PubMed ID: 9372964
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of a cDNA showing tumor-suppressive activity in V-SRC-transformed 3Y1 rat fibroblasts.
Sakiyama S; Ozaki T; Enomoto H
Adv Enzyme Regul; 1994; 34():247-55. PubMed ID: 7942277
[TBL] [Abstract][Full Text] [Related]
8. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines.
Kasukabe T; Okabe-Kado J; Honma Y
Blood; 1997 Apr; 89(8):2975-85. PubMed ID: 9108418
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras.
Lin X; Nelson PJ; Frankfort B; Tombler E; Johnson R; Gelman IH
Mol Cell Biol; 1995 May; 15(5):2754-62. PubMed ID: 7739556
[TBL] [Abstract][Full Text] [Related]
10. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.
Hajnal A; Klemenz R; Schäfer R
Oncogene; 1994 Feb; 9(2):479-90. PubMed ID: 8290259
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a unique complementary DNA of rat myosin regulatory light chain and its elevated expression in v-src-transformed rat culture cell lines.
Ozaki T; Asai T; Sakiyama S
Cell Growth Differ; 1993 Nov; 4(11):939-45. PubMed ID: 8297799
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
Cizdziel PE; Nash MA; Blair DG; Murphy EC
J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
[TBL] [Abstract][Full Text] [Related]
13. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression.
Hoemann CD; Zarbl H
Cell Growth Differ; 1990 Dec; 1(12):581-90. PubMed ID: 2126949
[TBL] [Abstract][Full Text] [Related]
14. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
[TBL] [Abstract][Full Text] [Related]
15. Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations in ras-, src-, and fos-transformed cells.
Borner C; Guadagno SN; Hsiao WW; Fabbro D; Barr M; Weinstein IB
J Biol Chem; 1992 Jun; 267(18):12900-10. PubMed ID: 1618788
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of v-mos-activated transformation-associated proteins.
Chan JC; Scanlon M; Zhang HZ; Jia LB; Yu DH; Hung MC; French M; Eastman EM
J Biol Chem; 1992 Jan; 267(2):1099-103. PubMed ID: 1370458
[TBL] [Abstract][Full Text] [Related]
17. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines.
Ozaki T; Sakiyama S
Oncogene; 1993 Jun; 8(6):1707-10. PubMed ID: 8389036
[TBL] [Abstract][Full Text] [Related]
19. Nickel-induced heritable alterations in retroviral transforming gene expression.
Biggart NW; Gallick GE; Murphy EC
J Virol; 1987 Aug; 61(8):2378-88. PubMed ID: 3037102
[TBL] [Abstract][Full Text] [Related]
20. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
Sergiescu D; Gerfaux J; Joret AM; Chany C
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
